We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
MRD | Mount Ridley Mines Ltd | 0.002 | 0.001 | 100.00% | 657,022 | 2 |
AUZOB | Australian Mines Ltd | 0.002 | 0.001 | 100.00% | 4,000,000 | 3 |
AARO | Astral Resources NL | 0.011 | 0.005 | 83.33% | 190,000 | 4 |
M4MOB | Macro Metals Ltd | 0.02 | 0.008 | 66.67% | 2,217,750 | 11 |
ION | Iondrive Limited | 0.011 | 0.004 | 57.14% | 3,017,992 | 30 |
BCMO | Brazilian Critical Minerals Ltd | 0.006 | 0.002 | 50.00% | 603,927 | 2 |
IBGO | Ironbark Zinc Limited | 0.003 | 0.001 | 50.00% | 233,333 | 1 |
RC1O | Redcastle Resources Ltd | 0.003 | 0.001 | 50.00% | 1,998,625 | 4 |
FAU | First AU Limited | 0.003 | 0.001 | 50.00% | 50,478,816 | 98 |
AVW | Avira Resources Limited | 0.0015 | 0.0005 | 50.00% | 699,500 | 2 |
KLI | Killi Resources Ltd | 0.042 | 0.011 | 35.48% | 524,295 | 6 |
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a potential multi-billion dollar revenue opportunity for Novavax including:$500 million upfront payment Approximately $70 million equity investment in NovavaxUp to $700 million in COVID-19 and combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTMÂ adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza Combination vaccine trial, which is on-track to initiate second half of 2024, with potential ...
Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based screening to create safer experiences, today announced financial results for the quarter ended March 31, 2024.
Translational Study Provides Pre-Clinical Evidence to Support The Design of a Phase 1 Study of the Hemopurifier In Cancer Patients With Solid Tumors Treated With Anti-PD-1 Antibodies SAN DIEGO, May 10, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced positive results from an in vitro binding study of its Hemopurifier® in removing extracellular vesicles (EVs) from plasma. The translational study provides pre-clinical evidence to support Aethlon's planned phase 1 safety, feasibility and dose-finding clinical trials of the Hemopurifier in patients with solid tumors ...
Growth Being Driven by Cleveland, OH and Virginia Beach, VA Locations Cashflows and EBITDA to be Accelerated Once its Second American Pulverizer 60x85 Shredder Commencing Operations CHESAPEAKE, Va., May 9, 2024 /PRNewswire/ -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (Nasdaq: GWAV), a leading operator of metal recycling facilities in Virginia, North Carolina, and Ohio, is pleased to report that it is expecting to generate revenues exceeding $40 million during the year ended December 31, 2024. Growth is being driven by its Cleveland, OH and Virginia Beach, VA locations. The Company expects its second American Pulverizer 60x85 shredder will ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 62,997.35 | -51.12 | -0.08% | 1.24T | 3,693,326,802 |
ETH | Ethereum | 3,026.89 | -9.21 | -0.30% | 363.34B | 1,437,405,728 |
USDT | Tether USD | 0.99991 | 0.00005 | 0.01% | 97.83B | 191,345,095 |
BNB | Binance Coin | 595.78 | -0.529954 | -0.09% | 94.02B | 248,970,629 |
SOL | Solana | 152.98 | 0.200 | 0.13% | 67.41B | 981,938,454 |
STETH | stETH | 3,024.55 | -10.34 | -0.34% | 29.51B | 2,589,328 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 801,721,123 |
XRP | Ripple | 0.5132 | -0.0078 | -1.50% | 27.97B | 242,990,452 |
TONCOIN | Wrapped TON Coin | 6.95 | 0.596243 | 9.38% | 24.05B | 356,166,035 |
DOGE | Dogecoin | 0.14974 | -0.00226 | -1.49% | 21.42B | 347,695,168 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions